The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Zhao, J.
	Articles by Lemoine, N. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Zhao, J.
	Articles by Lemoine, N. R.

Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R (1997). Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16, 3797-3804.[Medline]

Chen, Z. J., Parent, L. and Maniatis, T (1996). Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862.[Medline]

Ciechanover, A (1998). The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17, 7151-7160.[Medline]

Deveraux, Q. L. and Reed, J. C (1999). IAP family proteins \320 suppressors of apoptosis. Genes Dev 13, 239-252.[Free Full Text]

Deveraux, Q. L., Roy, N., Stennicke, H. R., Van Arsdale, T., Zhou, Q., Srinivasula, S. M., Alnemri, E. S., Salvesen, G. S. and Reed, J. C (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17, 2215-2223.[Medline]

Deveraux, Q. L., Takahashi, R., Salvesen, G. S. and Reed, J. C (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304.[Medline]

Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J. and Schreiber, S. L (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268, 726-731.[Abstract/Free Full Text]

Fraser, A. G., James, C., Evan, G. I. and Hengartner, M. O (1999). Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr. Biol 9, 292-301.[Medline]

Grossman, D., McNiff, J. M., Li, F. and Altieri, D. C (1999). Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol 113, 1076-1081.[Medline]

Grossman, D., McNiff, J. M., Li, F. and Altieri, D. C (1999). Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab. Invest 79, 1121-1126.[Medline]

Hateboer, G., Kerkhoven, R. M., Shvarts, A., Bernards, R. and Beijersbergen, R. L (1996). Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev 10, 2960-2970.[Abstract/Free Full Text]

Janknecht, R., de Martynoff, G., Lou, J., Hipskind, R. A., Nordheim, A. and Stunnenberg, H. G (1991). Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc. Natl. Acad. Sci. USA 88, 8972-8976.[Abstract/Free Full Text]

Kawasaki, H., Altieri, D. C., Lu, C. D., Toyoda, M., Tenjo, T. and Tanigawa, N (1998). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58, 5071-5074.[Abstract/Free Full Text]

King, R. W., Deshaies, R. J., Peters, J. M. and Kirschner, M. W (1996). How proteolysis drives the cell cycle. Science 274, 1652-1659.[Abstract/Free Full Text]

Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T. and Tokuhisa, T (1999). Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc. Natl. Acad. Sci. USA 96, 1457-1462.[Abstract/Free Full Text]

Koepp, D. M., Harper, J. W. and Elledge, S. J (1999). How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97, 431-434.[Medline]

LaCasse, E. C., Baird, S., Korneluk, R. G. and MacKenzie, A. E (1998). The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247-3259.[Medline]

Laney, J. D. and Hochstrasser, M (1999). Substrate targeting in the ubiquitin system. Cell 97, 427-430.[Medline]

Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C. and Altieri, D. C (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.[Medline]

Lu, C. D., Altieri, D. C. and Tanigawa, N (1998). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58, 1808-1812.[Abstract/Free Full Text]

Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M. and Byers, S. W (1997). Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J. Biol. Chem 272, 24735-24738.[Abstract/Free Full Text]

Patrick, G. N., Zhou, P., Kwon, Y. T., Howley, P. M. and Tsai, L. H (1998). p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J. Biol. Chem 273, 24057-24064.[Abstract/Free Full Text]

Roy, N., Deveraux, Q. L., Takahashi, R., Salvesen, G. S. and Reed, J. C (1997). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16, 6914-6925.[Medline]

Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. and Howley,P. M (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.[Medline]

Shirane, M., Harumiya, Y., Ishida, N., Hirai, A., Miyamoto, C., Hatakeyama, S., Nakayama, K. and Kitagawa, M (1999). Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol. Chem 274, 13886-13893.[Abstract/Free Full Text]

Sun, C., Cai, M., Gunasekera, A. H., Meadows, R. P., Wang, H., Chen, J., Zhang, H., Wu, W., Xu, N., Ng, S. C. and Fesik, S. W (1999). NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 401, 818-822.[Medline]

Takahashi, R., Deveraux, Q., Tamm, I., Welsh, K., Assa-Munt, N., Salvesen, G. S. and Reed, J. C (1998). A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273, 7787-7790.[Abstract/Free Full Text]

Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T. and Reed, J. C (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases and anticancer drugs. Cancer Res 58, 5315-5320.[Abstract/Free Full Text]

Tenev, T., Bohmer, S. A., Kaufmann, R., Frese, S., Bittorf, T., Beckers, T. and Bohmer, F. D (2000). Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells. Eur. J. Cell Biol 79, 261-271.[Medline]

Treier, M., Staszewski, L. M. and Bohmann, D (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798.[Medline]

Uren, A. G., Beilharz, T., O'Connell, M. J., Bugg, S. J., van Driel, R., Vaux, D. L. and Lithgow, T (1999). Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc. Natl. Acad. Sci. USA 96, 10170-10175.[Abstract/Free Full Text]

Ward, C. L., Omura, S. and Kopito, R. R (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127.[Medline]

Zhu, H., Kavsak, P., Abdollah, S., Wrana, J. L. and Thomsen, G. H (1999). A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693.[Medline]

This article has been cited by other articles:

M. Lu, A. Strohecker, F. Chen, T. Kwan, J. Bosman, V. C. Jordan, and V. L. Cryns
Aspirin Sensitizes Cancer Cells to TRAIL-Induced Apoptosis by Reducing Survivin Levels
Clin. Cancer Res., May 15, 2008; 14(10): 3168 - 3176.
[Abstract] [Full Text] [PDF]

C. M. Connell, R. Colnaghi, and S. P. Wheatley
Nuclear Survivin Has Reduced Stability and Is Not Cytoprotective
J. Biol. Chem., February 8, 2008; 283(6): 3289 - 3296.
[Abstract] [Full Text] [PDF]

V. Arora, H. H. Cheung, S. Plenchette, O. C. Micali, P. Liston, and R. G. Korneluk
Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex
J. Biol. Chem., September 7, 2007; 282(36): 26202 - 26209.
[Abstract] [Full Text] [PDF]

Y.-g. Son, E. H. Kim, J. Y. Kim, S. U. Kim, T. K. Kwon, A-R. Yoon, C.-O. Yun, and K. S. Choi
Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin
Cancer Res., September 1, 2007; 67(17): 8274 - 8284.
[Abstract] [Full Text] [PDF]

J. Y. Chun, Y. Hu, E. Pinder, J. Wu, F. Li, and A. C. Gao
Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter
Mol. Cancer Ther., September 1, 2007; 6(9): 2572 - 2580.
[Abstract] [Full Text] [PDF]

X. Liu, P. Yue, S. Chen, L. Hu, S. Lonial, F. R. Khuri, and S.-Y. Sun
The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells
Cancer Res., May 15, 2007; 67(10): 4981 - 4988.
[Abstract] [Full Text] [PDF]

P. Kumar, I. K. Coltas, B. Kumar, D. B. Chepeha, C. R. Bradford, and P. J. Polverini
Bcl-2 Protects Endothelial Cells against {gamma}-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release
Cancer Res., February 1, 2007; 67(3): 1193 - 1202.
[Abstract] [Full Text] [PDF]

N. Cosgrave, A. D K Hill, and L. S Young
Growth factor-dependent regulation of survivin by c-myc in human breast cancer
J. Mol. Endocrinol., December 1, 2006; 37(3): 377 - 390.
[Abstract] [Full Text] [PDF]

X. Huang and B. Guo
Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
Cancer Res., September 15, 2006; 66(18): 9245 - 9251.
[Abstract] [Full Text] [PDF]

R. Blum, J. Jacob-Hirsch, G. Rechavi, and Y. Kloog
Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis.
Mol. Cancer Ther., September 1, 2006; 5(9): 2337 - 2347.
[Abstract] [Full Text] [PDF]

W. Xia, J. Bisi, J. Strum, L. Liu, K. Carrick, K. M. Graham, A. L. Treece, M. A. Hardwicke, M. Dush, Q. Liao, et al.
Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
Cancer Res., February 1, 2006; 66(3): 1640 - 1647.
[Abstract] [Full Text] [PDF]

H. Asanuma, T. Torigoe, K. Kamiguchi, Y. Hirohashi, T. Ohmura, K. Hirata, M. Sato, and N. Sato
Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells
Cancer Res., December 1, 2005; 65(23): 11018 - 11025.
[Abstract] [Full Text] [PDF]

J. Huang, T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus
Nitric Oxide Sensitizes Tumor Cells to Dendritic Cell-Mediated Apoptosis, Uptake, and Cross-Presentation
Cancer Res., September 15, 2005; 65(18): 8461 - 8470.
[Abstract] [Full Text] [PDF]

F. Baratelli, K. Krysan, N. Heuze-Vourc'h, L. Zhu, B. Escuadro, S. Sharma, K. Reckamp, M. Dohadwala, and S. M. Dubinett
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells
J. Leukoc. Biol., August 1, 2005; 78(2): 555 - 564.
[Abstract] [Full Text] [PDF]

N. Schaft, J. Dorrie, P. Thumann, V. E. Beck, I. Muller, E. S. Schultz, E. Kampgen, D. Dieckmann, and G. Schuler
Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation
J. Immunol., March 1, 2005; 174(5): 3087 - 3097.
[Abstract] [Full Text] [PDF]

T. Samuel, K. Okada, M. Hyer, K. Welsh, J. M. Zapata, and J. C. Reed
cIAP1 Localizes to the Nuclear Compartment and Modulates the Cell Cycle
Cancer Res., January 1, 2005; 65(1): 210 - 218.
[Abstract] [Full Text] [PDF]

M. E. Johnson and E. W. Howerth
Survivin: A Bifunctional Inhibitor of Apoptosis Protein
Vet. Pathol., November 1, 2004; 41(6): 599 - 607.
[Abstract] [Full Text] [PDF]

C.-C. Chang, J. D. Heller, J. Kuo, and R. C. C. Huang
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression
PNAS, September 7, 2004; 101(36): 13239 - 13244.
[Abstract] [Full Text] [PDF]

J.-M. Hsu, Y.-C. G. Lee, C.-T. R. Yu, and C.-Y. F. Huang
Fbx7 Functions in the SCF Complex Regulating Cdk1-Cyclin B-phosphorylated Hepatoma Up-regulated Protein (HURP) Proteolysis by a Proline-rich Region
J. Biol. Chem., July 30, 2004; 279(31): 32592 - 32602.
[Abstract] [Full Text] [PDF]

Y. Zhang, Y. Nagata, G. Yu, H. G. Nguyen, M. R. Jones, P. Toselli, C. W. Jackson, M. Tatsuka, K. Todokoro, and K. Ravid
Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression
Blood, May 15, 2004; 103(10): 3717 - 3726.
[Abstract] [Full Text] [PDF]

E. J. Schlette, L. J. Medeiros, A. Goy, R. Lai, and G. Z. Rassidakis
Survivin Expression Predicts Poorer Prognosis in Anaplastic Large-Cell Lymphoma
J. Clin. Oncol., May 1, 2004; 22(9): 1682 - 1688.
[Abstract] [Full Text] [PDF]

H. Ando, H. Watabe, J. C. Valencia, K.-i. Yasumoto, M. Furumura, Y. Funasaka, M. Oka, M. Ichihashi, and V. J. Hearing
Fatty Acids Regulate Pigmentation via Proteasomal Degradation of Tyrosinase: A NEW ASPECT OF UBIQUITIN-PROTEASOME FUNCTION
J. Biol. Chem., April 9, 2004; 279(15): 15427 - 15433.
[Abstract] [Full Text] [PDF]

Z. Song, S. Liu, H. He, N. Hoti, Y. Wang, S. Feng, and M. Wu
A Single Amino Acid Change (Asp 53-> Ala53) Converts Survivin from Anti-apoptotic to Pro-apoptotic
Mol. Biol. Cell, March 1, 2004; 15(3): 1287 - 1296.
[Abstract] [Full Text] [PDF]

J. Geller, I. Petak, K. S. Szucs, K. Nagy, D. M. Tillman, and J. A. Houghton
Interferon-{gamma}-Induced Sensitization of Colon Carcinomas to ZD9331 Targets Caspases, Downstream of Fas, Independent of Mitochondrial Signaling and the Inhibitor of Apoptosis Survivin
Clin. Cancer Res., December 15, 2003; 9(17): 6504 - 6515.
[Abstract] [Full Text] [PDF]

V. Pisarev, B. Yu, R. Salup, S. Sherman, D. C. Altieri, and D. I. Gabrilovich
Full-Length Dominant-Negative Survivin for Cancer Immunotherapy
Clin. Cancer Res., December 15, 2003; 9(17): 6523 - 6533.
[Abstract] [Full Text] [PDF]

Z. Song, X. Yao, and M. Wu
Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis
J. Biol. Chem., June 13, 2003; 278(25): 23130 - 23140.
[Abstract] [Full Text] [PDF]

Y. Aoki, G. M. Feldman, and G. Tosato
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
Blood, February 15, 2003; 101(4): 1535 - 1542.
[Abstract] [Full Text] [PDF]

M. Leverkus, M. R. Sprick, T. Wachter, T. Mengling, B. Baumann, E. Serfling, E.-B. Brocker, M. Goebeler, M. Neumann, and H. Walczak
Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation
Mol. Cell. Biol., February 1, 2003; 23(3): 777 - 790.
[Abstract] [Full Text]

S. De Schepper, H. Bruwiere, T. Verhulst, U. Steller, L. Andries, W. Wouters, M. Janicot, J. Arts, and J. Van heusden
Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 881 - 888.
[Abstract] [Full Text] [PDF]

N. R. Wall, D. S. O'Connor, J. Plescia, Y. Pommier, and D. C. Altieri
Suppression of Survivin Phosphorylation on Thr34 by Flavopiridol Enhances Tumor Cell Apoptosis
Cancer Res., January 1, 2003; 63(1): 230 - 235.
[Abstract] [Full Text] [PDF]

A. Temme, M. Rieger, F. Reber, D. Lindemann, B. Weigle, P. Diestelkoetter-Bachert, G. Ehninger, M. Tatsuka, Y. Terada, and E. P. Rieber
Localization, Dynamics, and Function of Survivin Revealed by Expression of Functional SurvivinDsRed Fusion Proteins in the Living Cell
Mol. Biol. Cell, January 1, 2003; 14(1): 78 - 92.
[Abstract] [Full Text]

J Silke and D. Vaux
Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis
J. Cell Sci., January 5, 2001; 114(10): 1821 - 1827.
[Abstract] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Zhao, J.

Articles by Lemoine, N. R.

Search for Related Content

PubMed

PubMed Citation

Articles by Zhao, J.

Articles by Lemoine, N. R.

				C. M. Connell, R. Colnaghi, and S. P. Wheatley Nuclear Survivin Has Reduced Stability and Is Not Cytoprotective J. Biol. Chem., February 8, 2008; 283(6): 3289 - 3296. [Abstract] [Full Text] [PDF]

				V. Arora, H. H. Cheung, S. Plenchette, O. C. Micali, P. Liston, and R. G. Korneluk Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex J. Biol. Chem., September 7, 2007; 282(36): 26202 - 26209. [Abstract] [Full Text] [PDF]

				Y.-g. Son, E. H. Kim, J. Y. Kim, S. U. Kim, T. K. Kwon, A-R. Yoon, C.-O. Yun, and K. S. Choi Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin Cancer Res., September 1, 2007; 67(17): 8274 - 8284. [Abstract] [Full Text] [PDF]

				J. Y. Chun, Y. Hu, E. Pinder, J. Wu, F. Li, and A. C. Gao Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter Mol. Cancer Ther., September 1, 2007; 6(9): 2572 - 2580. [Abstract] [Full Text] [PDF]

				X. Liu, P. Yue, S. Chen, L. Hu, S. Lonial, F. R. Khuri, and S.-Y. Sun The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells Cancer Res., May 15, 2007; 67(10): 4981 - 4988. [Abstract] [Full Text] [PDF]

				P. Kumar, I. K. Coltas, B. Kumar, D. B. Chepeha, C. R. Bradford, and P. J. Polverini Bcl-2 Protects Endothelial Cells against {gamma}-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release Cancer Res., February 1, 2007; 67(3): 1193 - 1202. [Abstract] [Full Text] [PDF]

				N. Cosgrave, A. D K Hill, and L. S Young Growth factor-dependent regulation of survivin by c-myc in human breast cancer J. Mol. Endocrinol., December 1, 2006; 37(3): 377 - 390. [Abstract] [Full Text] [PDF]

				X. Huang and B. Guo Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. Cancer Res., September 15, 2006; 66(18): 9245 - 9251. [Abstract] [Full Text] [PDF]

				R. Blum, J. Jacob-Hirsch, G. Rechavi, and Y. Kloog Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis. Mol. Cancer Ther., September 1, 2006; 5(9): 2337 - 2347. [Abstract] [Full Text] [PDF]

				W. Xia, J. Bisi, J. Strum, L. Liu, K. Carrick, K. M. Graham, A. L. Treece, M. A. Hardwicke, M. Dush, Q. Liao, et al. Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers Cancer Res., February 1, 2006; 66(3): 1640 - 1647. [Abstract] [Full Text] [PDF]

				H. Asanuma, T. Torigoe, K. Kamiguchi, Y. Hirohashi, T. Ohmura, K. Hirata, M. Sato, and N. Sato Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells Cancer Res., December 1, 2005; 65(23): 11018 - 11025. [Abstract] [Full Text] [PDF]

				J. Huang, T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus Nitric Oxide Sensitizes Tumor Cells to Dendritic Cell-Mediated Apoptosis, Uptake, and Cross-Presentation Cancer Res., September 15, 2005; 65(18): 8461 - 8470. [Abstract] [Full Text] [PDF]

				F. Baratelli, K. Krysan, N. Heuze-Vourc'h, L. Zhu, B. Escuadro, S. Sharma, K. Reckamp, M. Dohadwala, and S. M. Dubinett PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells J. Leukoc. Biol., August 1, 2005; 78(2): 555 - 564. [Abstract] [Full Text] [PDF]

				N. Schaft, J. Dorrie, P. Thumann, V. E. Beck, I. Muller, E. S. Schultz, E. Kampgen, D. Dieckmann, and G. Schuler Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation J. Immunol., March 1, 2005; 174(5): 3087 - 3097. [Abstract] [Full Text] [PDF]

				T. Samuel, K. Okada, M. Hyer, K. Welsh, J. M. Zapata, and J. C. Reed cIAP1 Localizes to the Nuclear Compartment and Modulates the Cell Cycle Cancer Res., January 1, 2005; 65(1): 210 - 218. [Abstract] [Full Text] [PDF]

				M. E. Johnson and E. W. Howerth Survivin: A Bifunctional Inhibitor of Apoptosis Protein Vet. Pathol., November 1, 2004; 41(6): 599 - 607. [Abstract] [Full Text] [PDF]

				C.-C. Chang, J. D. Heller, J. Kuo, and R. C. C. Huang Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression PNAS, September 7, 2004; 101(36): 13239 - 13244. [Abstract] [Full Text] [PDF]

				J.-M. Hsu, Y.-C. G. Lee, C.-T. R. Yu, and C.-Y. F. Huang Fbx7 Functions in the SCF Complex Regulating Cdk1-Cyclin B-phosphorylated Hepatoma Up-regulated Protein (HURP) Proteolysis by a Proline-rich Region J. Biol. Chem., July 30, 2004; 279(31): 32592 - 32602. [Abstract] [Full Text] [PDF]

				Y. Zhang, Y. Nagata, G. Yu, H. G. Nguyen, M. R. Jones, P. Toselli, C. W. Jackson, M. Tatsuka, K. Todokoro, and K. Ravid Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression Blood, May 15, 2004; 103(10): 3717 - 3726. [Abstract] [Full Text] [PDF]

				E. J. Schlette, L. J. Medeiros, A. Goy, R. Lai, and G. Z. Rassidakis Survivin Expression Predicts Poorer Prognosis in Anaplastic Large-Cell Lymphoma J. Clin. Oncol., May 1, 2004; 22(9): 1682 - 1688. [Abstract] [Full Text] [PDF]

				H. Ando, H. Watabe, J. C. Valencia, K.-i. Yasumoto, M. Furumura, Y. Funasaka, M. Oka, M. Ichihashi, and V. J. Hearing Fatty Acids Regulate Pigmentation via Proteasomal Degradation of Tyrosinase: A NEW ASPECT OF UBIQUITIN-PROTEASOME FUNCTION J. Biol. Chem., April 9, 2004; 279(15): 15427 - 15433. [Abstract] [Full Text] [PDF]

				Z. Song, S. Liu, H. He, N. Hoti, Y. Wang, S. Feng, and M. Wu A Single Amino Acid Change (Asp 53-> Ala53) Converts Survivin from Anti-apoptotic to Pro-apoptotic Mol. Biol. Cell, March 1, 2004; 15(3): 1287 - 1296. [Abstract] [Full Text] [PDF]

				J. Geller, I. Petak, K. S. Szucs, K. Nagy, D. M. Tillman, and J. A. Houghton Interferon-{gamma}-Induced Sensitization of Colon Carcinomas to ZD9331 Targets Caspases, Downstream of Fas, Independent of Mitochondrial Signaling and the Inhibitor of Apoptosis Survivin Clin. Cancer Res., December 15, 2003; 9(17): 6504 - 6515. [Abstract] [Full Text] [PDF]

				V. Pisarev, B. Yu, R. Salup, S. Sherman, D. C. Altieri, and D. I. Gabrilovich Full-Length Dominant-Negative Survivin for Cancer Immunotherapy Clin. Cancer Res., December 15, 2003; 9(17): 6523 - 6533. [Abstract] [Full Text] [PDF]

				Z. Song, X. Yao, and M. Wu Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis J. Biol. Chem., June 13, 2003; 278(25): 23130 - 23140. [Abstract] [Full Text] [PDF]

				Y. Aoki, G. M. Feldman, and G. Tosato Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma Blood, February 15, 2003; 101(4): 1535 - 1542. [Abstract] [Full Text] [PDF]

				M. Leverkus, M. R. Sprick, T. Wachter, T. Mengling, B. Baumann, E. Serfling, E.-B. Brocker, M. Goebeler, M. Neumann, and H. Walczak Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation Mol. Cell. Biol., February 1, 2003; 23(3): 777 - 790. [Abstract] [Full Text]

				S. De Schepper, H. Bruwiere, T. Verhulst, U. Steller, L. Andries, W. Wouters, M. Janicot, J. Arts, and J. Van heusden Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 881 - 888. [Abstract] [Full Text] [PDF]

				N. R. Wall, D. S. O'Connor, J. Plescia, Y. Pommier, and D. C. Altieri Suppression of Survivin Phosphorylation on Thr34 by Flavopiridol Enhances Tumor Cell Apoptosis Cancer Res., January 1, 2003; 63(1): 230 - 235. [Abstract] [Full Text] [PDF]

				A. Temme, M. Rieger, F. Reber, D. Lindemann, B. Weigle, P. Diestelkoetter-Bachert, G. Ehninger, M. Tatsuka, Y. Terada, and E. P. Rieber Localization, Dynamics, and Function of Survivin Revealed by Expression of Functional SurvivinDsRed Fusion Proteins in the Living Cell Mol. Biol. Cell, January 1, 2003; 14(1): 78 - 92. [Abstract] [Full Text]